Parallel Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.57K | Buy |
87
+31
| +55% | +$1.99K | ﹤0.01% | 2675 |
|
|
2025
Q1 | $3.54K | Buy |
56
+1
| +2% | +$63 | ﹤0.01% | 2787 |
|
|
2024
Q4 | $3.71K | Hold |
55
| – | – | ﹤0.01% | 2727 |
|
|
2024
Q3 | $3.9K | Sell |
55
-1
| -2% | -$71 | ﹤0.01% | 2684 |
|
|
2024
Q2 | $3.62K | Hold |
56
| – | – | ﹤0.01% | 2609 |
|
|
2024
Q1 | $3.61K | Hold |
56
| – | – | ﹤0.01% | 2623 |
|
|
2023
Q4 | $3.67K | Buy |
56
+1
| +2% | +$66 | ﹤0.01% | 2613 |
|
|
2023
Q3 | $3.18K | Sell |
55
-691
| -93% | -$40K | ﹤0.01% | 2666 |
|
|
2023
Q2 | $45.8K | Buy |
+746
| New | +$45.8K | ﹤0.01% | 1436 |
|